Active Pharmaceutical Ingredient (API) Prequalified

WHO

REGULATORY UPDATE

Published: 11/11/2026Detected: 11/11/2026

Summary preview

Prequalifies tenofovir disoproxil fumarate API manufactured by Viyash Scientific Limited under WHO’s API prequalification procedure, supporting downstream manufacture of WHO-recommended quality medicines for HIV/AIDS.

Get the full analysis, free

Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.

#WHO prequalification

#active pharmaceutical ingredient

#APIMF

#WHO GMP

#tenofovir disoproxil fumarate

Official Source Document
Source Verified

Access the original document directly from WHO.

View Official Document

More from WHO

Invitation to a Webinar on managing reportable changes11/11/2026
WHO Prequalifies Two STANDARD Q Malaria Rapid Diagnostic Tests11/11/2026
VCP Updates - October 202611/11/2026
In Vitro Diagnostics Assessment Sessions for 202711/11/2026
New WHO Emergency Use Listing for Ebola diagnostics11/11/2026

Get WHO alerts in your inbox as they are published.

Free plan, 2-minute setup, no credit card required.

Security

Privacy Policy

Terms of Service

Not affiliated with the FDA, EMA, or Health Canada.

Summary preview

Get the full analysis, free

Official Source Document Source Verified

More from WHO

Get WHO alerts in your inbox as they are published.

Official Source Document
Source Verified